千億收購後，波科再完成一項重大收購

藥智醫械數據

02/02

近期，據外媒報道，波士頓科學已完成對Nalu醫療公司的收購。圖片來源：Latest Medical Device News on MassDevice據悉，波科曾於2025年10月宣佈達成收購Nalu的協議。早在2017年，波科便是Nalu的戰略投資者。本次交易中，波士頓科學同意支付約5.33億美元現金，以收購該公司的剩餘股權。不過值得注意的是，雖然波士頓科學已在Nalu擁有股權，但本次交易總價仍...

網頁鏈接

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2608819258"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2608819258\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2608819258?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-02-02 10:27","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2608819258","market":"us","top_or_hot":-1,"title":"千億收購後，波科再完成一項重大收購","media":"藥智醫械數據","content":"<div>\n<p>近期，據外媒報道，波士頓科學已完成對Nalu醫療公司的收購。圖片來源：Latest Medical Device News on MassDevice據悉，波科曾於2025年10月宣佈達成收購Nalu的協議。早在2017年，波科便是Nalu的戰略投資者。本次交易中，波士頓科學同意支付約5.33億美元現金，以收購該公司的剩餘股權。不過值得注意的是，雖然波士頓科學已在Nalu擁有股權，但本次交易總價仍...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202104508a47158b5&s=b\">網頁鏈接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>千億收購後，波科再完成一項重大收購</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n千億收購後，波科再完成一項重大收購\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">藥智醫械數據</strong><span class=\"h-time small\">2026-02-02 10:27</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>近期，據外媒報道，波士頓科學已完成對Nalu醫療公司的收購。圖片來源：Latest Medical Device News on MassDevice據悉，波科曾於2025年10月宣佈達成收購Nalu的協議。早在2017年，波科便是Nalu的戰略投資者。本次交易中，波士頓科學同意支付約5.33億美元現金，以收購該公司的剩餘股權。不過值得注意的是，雖然波士頓科學已在Nalu擁有股權，但本次交易總價仍...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202104508a47158b5&s=b\">網頁鏈接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202104508a47158b5&s=b\">藥智醫械數據</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2112291526.USD","symbol_name":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202104508a47158b5&s=b","article_id":"2608819258","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202104508a47158b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2608819258","pubTimestamp":1769999238,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"近期，據外媒報道，波士頓科學已完成對Nalu醫療公司的收購。圖片來源：Latest Medical Device News on MassDevice據悉，波科曾於2025年10月宣佈達成收購Nalu的協議。本次交易中，波士頓科學同意支付約5.33億美元現金，以收購該公司的剩餘股權。對於本次交易，波科表示通過收購Nalu公司，將有效拓展其慢性疼痛產品組合，並且波科預計，Nalu在2025年的收入將超過6000萬美元，並且將持續保持增長趨勢，有望在2026年得到超25%的增長。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU1718418525.SGD":"JPMorgan Investment Funds - Global Select Equity A (acc) SGD","LU1366192091.USD":"ALLIANZ US EQUITY PLUS \"AM\" (USD) INC","LU2242649171.HKD":"FIDELITY FUNDS GLOBAL THEMATIC OPPORTUNITIES \"A\" (HKD) ACC","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","LU0011850046.USD":"贝莱德全球长线股票 A2 USD","BK4585":"ETF&股票定投概念","LU0048584097.USD":"FIDELITY FUNDS  GLOBAL THEMATIC OPPORTUNITIES \"A\" (USD) INC","BSX":"波士顿科学","LU0882574055.USD":"富达全球健康医疗A ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU0225283273.USD":"SCHRODER ISF GLOBAL EQUITY ALPHA \"A\" (USD) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU0238689110.USD":"贝莱德环球动力股票基金","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","LU0187121727.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) INC","LU0251132253.USD":"FIDELITY FUNDS  GLOBAL THEMATIC OPPORTUNITIES \"A\" (USD) ACC","LU2506951875.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) ACC","BK4082":"医疗保健设备","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU2244417387.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) ACC","LU2506952097.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) ACC","BK4504":"桥水持仓","LU0077335932.USD":"FIDELITY AMERICAN GROWTH \"A\" INC","SG9999001176.USD":"United Global Healthcare Acc USD","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU0823417737.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC","BK4588":"碎股","LU2506951958.HKD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (HKDHDG) INC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU2087625088.SGD":"ALLSPRING  US ALL CAP GROWTH \"A\" (SGDHDG) ACC","LU0950375773.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"C\" (USD) INC A","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU2362540622.SGD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (SGDHDG) ACC","LU2506952170.USD":"BNP PARIBAS SUSTAINABLE GLOBAL LOW VOL EQUITY \"CRH\" (USDHDG) INC","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC"},"translate_title":"After the 100 billion acquisition, Poco completes another major acquisition","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSX":0.9},"content_text":"近期，據外媒報道，波士頓科學已完成對Nalu醫療公司的收購。圖片來源：Latest Medical Device News on MassDevice據悉，波科曾於2025年10月宣佈達成收購Nalu的協議。早在2017年，波科便是Nalu的戰略投資者。本次交易中，波士頓科學同意支付約5.33億美元現金，以收購該公司的剩餘股權。不過值得注意的是，雖然波士頓科學已在Nalu擁有股權，但本次交易總價仍包含一筆6億美元（摺合人民幣約42億元）的預付現金。Nalu公司是一家專注於脊髓刺激和周圍神經刺激技術的醫療器械企業。其產品旨在治療慢性神經性疼痛患者，通過向神經系統傳遞温和的電脈衝，在疼痛信號到達大腦之前對其進行調節。據查詢，Nalu系統包括一個功能齊全、無需電池、微型化的植入式脈衝發生器。一個外部佩戴的治療盤為IPG無線供電，用户可通過智能手機應用程序進行控制。公司表示，儘管其IPG尺寸更小，但提供的治療能力與大型IPG相似。Nalu系統的預期使用壽命為18年。2025年，Nalu公司獲得了美國FDA對其周圍神經刺激系統治療的批准，允許在全身MRI中使用。其最初獲得FDA批准是在2019年。去年8月，Nalu還為該平台推出了微型可穿戴電源，隨後在次月獲得了5000萬美元的增長資金。值得一提的是，此前，Nalu公司還任命Axonics前創始人兼首席執行官Raymond W. Cohen加入其董事會並擔任主席。而Cohen曾領導Axonics在2024年被波士頓科學收購。對於本次交易，波科表示通過收購Nalu公司，將有效拓展其慢性疼痛產品組合，並且波科預計，Nalu在2025年的收入將超過6000萬美元，並且將持續保持增長趨勢，有望在2026年得到超25%的增長。近年來，波科完成了多項收購：2024年9月以11.8億美元收購Silk Road Medical；2024年11月以37億美元收購Axonics；2025年1月，收購Bolt Medical，並於3月完成交易；2025年5月，完成了對血管內超聲開發商SoniVie的收購；2025年10月，8800萬美元完成了對Elutia生物包膜技術的收購。而在2026年開年，更是官宣了其在併購歷史生涯中，金額達第二的鉅額收購，以145億美元收購Penumbra，該筆鉅額收購距本次收購完成僅數周時間。免費領取藥智數據VIP試用：https://vip.yaozh.com/introducemobile?tryout=1&ga_source=zimeiti&ga_name=yzw_wz聲明：本文僅作信息傳遞之目的，並不代表本平台觀點，本文不是治療方案推薦，也不構成投資建議。如涉及作品內容、版權和其它問題，請在本平台留言，我們將在第一時間核實並處理。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"corporation,merge","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}